FST and metabolic dysfunction-associated steatotic liver disease: In bidirectional MR analyses, there was little evidence that mediators decreased or increased these proteins significantly, except the associations between HOMA-B and CTSA, SHBG and FST, as well as NAFLD and RSPO3 (Supplementary Table 6).